Hot Features
Premium
Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Período:
Tipo de Línea:
| Volume | 0 |
|
|||||
| Noticias | - |
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Summit Therapeutics Inc | SMMT | NASDAQ | Certificado de Depósito |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 4.39 | 19:00:00 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 4.39 |
| Operaciones | Volume Operado de la Acción | Volumen promedio |
|---|---|---|
| 0 | 0 | - |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| - | 0 | 4.39 | USD |
Información Financiera Summit Therapeutics Inc SMMT
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 3.08B | 700.84M | - | 1M | -614.93M | -0.88 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Summit Therapeutics Inc SMMT
| Fecha | Hora | Fuente | Noticia |
|---|---|---|---|
| 13/5/2024 | 07:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 13/5/2024 | 06:48 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 01/5/2024 | 06:00 | Business Wire | Summit Therapeutics Reports Financial Results and.. |
| 24/4/2024 | 15:30 | Business Wire | Summit Therapeutics to Host First Quarter 2024 Financial.. |
| 11/4/2024 | 15:30 | Business Wire | Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned.. |
| 10/4/2024 | 06:00 | Business Wire | Summit Therapeutics to Present at the Stifel 2024 Targeted.. |
| 22/3/2024 | 06:00 | Business Wire | Promising Intracranial Anti-Tumor Activity and Safety Data.. |
| 14/3/2024 | 06:00 | Business Wire | Intracranial Anti-Tumor Activity and Safety of Ivonescimab.. |
| 05/3/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05/3/2024 | 06:00 | Business Wire | Summit Therapeutics to Present at the Barclays 26th Annual.. |
| 20/2/2024 | 07:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20/2/2024 | 06:55 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
Histórico SMMT
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
